Novo Nordisk-BBDC Pilot And Feasibility Grants 2022/2023
Application Deadline Date: November 23, 2021
| Recipient | Title of Research | Amount |
| Dr. Andrew Advani | Discovering inflammation-driven post-translational modification in heart cells in diabetes | $40,000 |
| Dr. Jacqueline Beaudry | Inhibiting the Glucose-dependent Insulinotropic Receptor (GIPR) on Lipid Metabolism in Activated Brown Adipose Tissue | $40,000 |
| Dr. Michael Wheeler | Connecting Specific Central GLP-1 Receptors Functionally with Glucose Homeostasis and Energy Balance | $40,000 |